| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |